Circulating miR-26a, miR-106b, miR-107 and miR-133b stratify hepatocellular carcinoma patients according to their response to transarterial chemoembolization

BACKGROUND: A number of hepatocellular carcinoma (HCC) patients have developed resistance against transcatheter arterial chemoembolization (TACE) treatment. In this study, we aimed to develop a panel of microRNAs (miRs) biomarkers to predict clinical outcomes in HCC patients after TACE treatment. ME...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Biochem
Hlavní autoři: Ali, Hamdy EA, Emam, Ahmed A., Zeeneldin, Ahmed A., Srour, Reham, Tabashy, Reda, El-Desouky, Eman D., Elmageed, Zakaria Y. Abd, Abdel-Wahab, Abdel-Hady A.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2019
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6397777/
https://ncbi.nlm.nih.gov/pubmed/30653948
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clinbiochem.2019.01.002
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky